Hematopoietic Cell Transplantation in Primary Myelofibrosis

Irum Khan; Damiano Rondelli

doi:10.1002/9781118589199.ch30

Hematopoietic Cell Transplantation in Primary Myelofibrosis

Irum Khan^*, Damiano Rondelli

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This chapter presents a series of questions and answers on hematopoietic cell transplantation in primary myelofibrosis. It commences with a discourse on cure for myelofibrosis, and ends with the availability of new agents for myelofibrosis change the role of hematopoietic stem cell transplantation (HSCT). The chapter also discusses on myeloablative or reduced-intensity conditioning, main complications of HSCT, marker of posttransplant minimal residual disease (MRD), and role for donor lymphocyte infusions (DLIs) or second allograft in relapse post HSCT.

Original language	English (US)
Title of host publication	Cancer Consult
Subtitle of host publication	Expertise for Clinical Practice
Publisher	Wiley-Blackwell
Pages	187-191
Number of pages	5
ISBN (Electronic)	9781118589199
ISBN (Print)	9781118589212
DOIs	https://doi.org/10.1002/9781118589199.ch30
State	Published - Jun 20 2014

Keywords

Donor lymphocyte infusions (DLIs)
Hematopoietic stem cell transplantation (HSCT)
Minimal residual disease (MRD)
Myelofibrosis

ASJC Scopus subject areas

General Medicine

Access to Document

10.1002/9781118589199.ch30

Cite this

@inbook{2da7456ae95f4d60b292bb30d70edcc0,

title = "Hematopoietic Cell Transplantation in Primary Myelofibrosis",

abstract = "This chapter presents a series of questions and answers on hematopoietic cell transplantation in primary myelofibrosis. It commences with a discourse on cure for myelofibrosis, and ends with the availability of new agents for myelofibrosis change the role of hematopoietic stem cell transplantation (HSCT). The chapter also discusses on myeloablative or reduced-intensity conditioning, main complications of HSCT, marker of posttransplant minimal residual disease (MRD), and role for donor lymphocyte infusions (DLIs) or second allograft in relapse post HSCT.",

keywords = "Donor lymphocyte infusions (DLIs), Hematopoietic stem cell transplantation (HSCT), Minimal residual disease (MRD), Myelofibrosis",

author = "Irum Khan and Damiano Rondelli",

note = "Publisher Copyright: {\textcopyright} 2014 John Wiley and Sons, Inc.",

year = "2014",

month = jun,

day = "20",

doi = "10.1002/9781118589199.ch30",

language = "English (US)",

isbn = "9781118589212",

pages = "187--191",

booktitle = "Cancer Consult",

publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Hematopoietic Cell Transplantation in Primary Myelofibrosis

AU - Khan, Irum

AU - Rondelli, Damiano

PY - 2014/6/20

Y1 - 2014/6/20

N2 - This chapter presents a series of questions and answers on hematopoietic cell transplantation in primary myelofibrosis. It commences with a discourse on cure for myelofibrosis, and ends with the availability of new agents for myelofibrosis change the role of hematopoietic stem cell transplantation (HSCT). The chapter also discusses on myeloablative or reduced-intensity conditioning, main complications of HSCT, marker of posttransplant minimal residual disease (MRD), and role for donor lymphocyte infusions (DLIs) or second allograft in relapse post HSCT.

AB - This chapter presents a series of questions and answers on hematopoietic cell transplantation in primary myelofibrosis. It commences with a discourse on cure for myelofibrosis, and ends with the availability of new agents for myelofibrosis change the role of hematopoietic stem cell transplantation (HSCT). The chapter also discusses on myeloablative or reduced-intensity conditioning, main complications of HSCT, marker of posttransplant minimal residual disease (MRD), and role for donor lymphocyte infusions (DLIs) or second allograft in relapse post HSCT.

KW - Donor lymphocyte infusions (DLIs)

KW - Hematopoietic stem cell transplantation (HSCT)

KW - Minimal residual disease (MRD)

KW - Myelofibrosis

UR - http://www.scopus.com/inward/record.url?scp=84946402645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946402645&partnerID=8YFLogxK

U2 - 10.1002/9781118589199.ch30

DO - 10.1002/9781118589199.ch30

M3 - Chapter

AN - SCOPUS:84946402645

SN - 9781118589212

SP - 187

EP - 191

BT - Cancer Consult

PB - Wiley-Blackwell

ER -

Hematopoietic Cell Transplantation in Primary Myelofibrosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this